Aijaz Gundroo is a Nephrology physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 24 publications with 1,008 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
543 Taylor Ave
Columbus, OH 432031278
Telephone
614-293-4837Provider last certified this registry record 31 Mar 2026.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mallinckrodt Hospital Products Inc.Program year20251 payment
- Travere Therapeutics, Inc.Program year20253 payments
- GlaxoSmithKline, LLC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
37.5%Calcium channel blocker16%Amlodipine Besylate54%Nifedipine Er46%Part D<11 patientsLoop diuretic10.8%Furosemide100%Part D≥13 patients+ 2 more classes in this area
Metabolism & gastrointestinal
19.4%Corticosteroid6.9%Prednisone100%Part D<11 patientsSGLT2 inhibitor4.2%Jardiance100%Part D<11 patients+ 2 more classes in this area
Anti-infectives
11.5%Short-acting sulfonamides11.5%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Bayesian optimization of tacrolimus exposure in stable kidney transplant patients
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
2023 - Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
2022 - Successful corticosteroid therapy for exenatideinduced acute interstitial nephritis
Clinical Nephrology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Colleen Cebulla, MD
The Ohio State University Wexner Medical Center
Michael Grever, MD
The Ohio State University Wexner Medical Center
Brad Rovin, MD
The Ohio State University Wexner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”